Delivery Order SPE2DB24D9238-SPE2DB25FDRBX
- Not listed
- The Defense Logistics Agency awarded a $41,661.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, effective September 11, 2025, with an ultimate completion date of October 2, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation to supply this contraceptive implant device. This delivery order is issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $7,811.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. The award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, a contraceptive implant device. The contract, issued on June 6, 2025, with an ultimate completion date of June 30, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery from its Illinois location. This...
- The Defense Logistics Agency awarded a $6,249.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a hormonal contraceptive implant device. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a delivery order under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $500 million through November 2026. This delivery order does not include a set-aside designation, and the...
- The Defense Logistics Agency awarded a $26,038.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of October 3, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price contracting without a set-aside designation. The delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a $12,498.48 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant device. The delivery order, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, represents a single procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $500 million through November 2026. The order will be fulfilled from the contractor's...
- The Defense Logistics Agency awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a specific product requisition issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, a contraceptive implant device. Issued on August 20, 2025, with completion targeted for September 11, 2025, this firm fixed-price delivery order represents a standard pharmaceutical supply transaction under the agency's medical procurement operations. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, valued at $10,415.40 with a firm fixed-price structure, was issued on September 23, 2025, with an ultimate completion date of October 15, 2025. This award carries no set-aside designation and represents a single delivery order under DMS...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDRBXDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $20,830.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on September 23, 2025, covers Mirena 52 mg systems (a contraceptive implant device) and is expected to be completed by October 15, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a qualified federal supplier. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, leveraging its established position as a woman-owned small business to provide branded and generic prescription medications, biologics, medical consumables, and specialty pharmaceutical products to military health facilities. The company's federal contract portfolio demonstrates consistent success in securing delivery orders for diverse medical products ranging from vaccines and contraceptive devices to oncology treatments. This particular award for Mirena systems reflects the company's specialized capability in providing pharmaceutical and medical device solutions that support the healthcare needs of Department of Defense personnel and facilities across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.8k | 9/23/25 |